Nektar TherapeuticsNKTRNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-208.68M
↓ 39% vs avg
Percentile
P29
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-150.17M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-208.68M | -17.8% |
| 2024 | $-177.18M | +8.4% |
| 2023 | $-193.47M | +37.5% |
| 2022 | $-309.68M | +27.6% |
| 2021 | $-427.65M | -33.4% |
| 2020 | $-320.55M | +9.7% |
| 2019 | $-354.97M | -150.4% |
| 2018 | $703.98M | +881.4% |
| 2017 | $-90.09M | +27.0% |
| 2016 | $-123.42M | - |